Ignite Creation Date:
2024-05-05 @ 9:42 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00003210
Status:
COMPLETED
Last Update Posted:
2015-04-15
First Post:
1999-11-01
Brief Title:
Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkins Lymphoma or Hodgkins Disease
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Waldenström Macroglobulinemia |
| Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue |
| Nodal Marginal Zone B-cell Lymphoma |
| Recurrent Adult Diffuse Large Cell Lymphoma |
| Recurrent Adult Diffuse Mixed Cell Lymphoma |
| Recurrent Adult Diffuse Small Cleaved Cell Lymphoma |
| Recurrent Adult Hodgkin Lymphoma |
| Recurrent Adult Immunoblastic Large Cell Lymphoma |
| Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma |
| Recurrent Grade 1 Follicular Lymphoma |
| Recurrent Grade 2 Follicular Lymphoma |
| Recurrent Grade 3 Follicular Lymphoma |
| Recurrent Mantle Cell Lymphoma |
| Recurrent Marginal Zone Lymphoma |
| Recurrent Mycosis FungoidesSezary Syndrome |
| Recurrent Small Lymphocytic Lymphoma |
| Splenic Marginal Zone Lymphoma |
Keywords: